{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-062109","form_type":"8-K","ticker":"QUCY","cik":"0001874252","company_name":"Quantum Cyber N.V.","filed_at":"2026-05-28T20:05:36+00:00","discovered_at":"2026-05-28T20:07:00.324691+00:00","generated_at":"2026-05-28T21:16:51.731985+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Quantum Cyber regains Nasdaq minimum bid price compliance; deficiency notice closed","bullets":["Received Nasdaq letter on May 28, 2026 confirming bid price >=$1.00 for 10 consecutive business days (May 13-27, 2026).","Previously notified of deficiency on March 20, 2026 for failing minimum bid price requirement.","Company now compliant with Nasdaq Listing Rule 5550(a)(2); matter closed."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-062109","json":"https://secwatch.observer/filing/0001213900-26-062109.json","markdown":"https://secwatch.observer/filing/0001213900-26-062109.md","text":"https://secwatch.observer/filing/0001213900-26-062109.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1874252/000121390026062109/0001213900-26-062109-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1874252/000121390026062109/ea0292568-8k_quantum.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T21:16:51.731985+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"comparable_filings":[{"accession":"0001628280-26-039424","ticker":"RICK","company_name":"RCI HOSPITALITY HOLDINGS, INC.","filed_at":"2026-06-01T19:08:52+00:00","headline":"RCI Hospitality regains Nasdaq compliance after filing delayed Q1 10-Q","event_type":"regulatory","sec_items":["8.01","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same SEC item: 8.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-039424","json":"https://secwatch.observer/filing/0001628280-26-039424.json","markdown":"https://secwatch.observer/filing/0001628280-26-039424.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/935419/000162828026039424/0001628280-26-039424-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/935419/000162828026039424/rick-20260529.htm"},"side_by_side_evidence":null},{"accession":"0001104659-26-067517","ticker":"CLIR","company_name":"ClearSign Technologies Corp","filed_at":"2026-05-28T20:19:02+00:00","headline":"ClearSign Technologies suspends ATM prospectus supplement for $10.39 million common stock offering; no shares sold","event_type":"regulatory","sec_items":["8.01","9.01"],"materiality_score":0.3,"calibrated_materiality_score":0.3,"match_reasons":["same SEC item: 8.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-067517","json":"https://secwatch.observer/filing/0001104659-26-067517.json","markdown":"https://secwatch.observer/filing/0001104659-26-067517.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1434524/000110465926067517/0001104659-26-067517-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1434524/000110465926067517/tm2615697d1_8k.htm"},"side_by_side_evidence":null},{"accession":"0001213900-26-057182","ticker":"PFSA","company_name":"Profusa, Inc.","filed_at":"2026-05-15T12:58:49+00:00","headline":"Profusa transfers to Nasdaq Capital Market on May 15, 2026, under panel compliance plan","event_type":"regulatory","sec_items":["8.01","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same SEC item: 8.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-057182","json":"https://secwatch.observer/filing/0001213900-26-057182.json","markdown":"https://secwatch.observer/filing/0001213900-26-057182.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1859807/000121390026057182/0001213900-26-057182-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1859807/000121390026057182/ea0291023-8k_profusa.htm"},"side_by_side_evidence":null},{"accession":"0001213900-26-056656","ticker":"AIRE","company_name":"reAlpha Tech Corp.","filed_at":"2026-05-14T20:20:34+00:00","headline":"reAlpha regains Nasdaq minimum bid price compliance; matter closed","event_type":"regulatory","sec_items":["8.01","9.01"],"materiality_score":0.3,"calibrated_materiality_score":0.3,"match_reasons":["same SEC item: 8.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-056656","json":"https://secwatch.observer/filing/0001213900-26-056656.json","markdown":"https://secwatch.observer/filing/0001213900-26-056656.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1859199/000121390026056656/0001213900-26-056656-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1859199/000121390026056656/ea0290935-8k_realpha.htm"},"side_by_side_evidence":null},{"accession":"0001193125-26-221574","ticker":"PSNL","company_name":"Personalis, Inc.","filed_at":"2026-05-13T20:03:04+00:00","headline":"CMS expands Medicare coverage for Personalis' NeXT Personal test to immunotherapy monitoring","event_type":"regulatory","sec_items":["8.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same SEC item: 8.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-221574","json":"https://secwatch.observer/filing/0001193125-26-221574.json","markdown":"https://secwatch.observer/filing/0001193125-26-221574.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1527753/000119312526221574/0001193125-26-221574-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1527753/000119312526221574/psnl-20260512.htm"},"side_by_side_evidence":null},{"accession":"0001193125-26-251517","ticker":"LESL","company_name":"Leslie's, Inc.","filed_at":"2026-06-01T20:28:42+00:00","headline":"Leslie's regains Nasdaq compliance for minimum market value of publicly held shares","event_type":"regulatory","sec_items":["8.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same SEC item: 8.01","same event type: regulatory"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-251517","json":"https://secwatch.observer/filing/0001193125-26-251517.json","markdown":"https://secwatch.observer/filing/0001193125-26-251517.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1821806/000119312526251517/0001193125-26-251517-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1821806/000119312526251517/lesl-20260529.htm"},"side_by_side_evidence":null},{"accession":"0001104659-26-068659","ticker":"OTLK","company_name":"Outlook Therapeutics, Inc.","filed_at":"2026-06-01T13:15:32+00:00","headline":"Outlook Therapeutics resubmits BLA for ONS-5010 to FDA; Class 1 review, PDUFA in 60 days","event_type":"regulatory","sec_items":["8.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same SEC item: 8.01","same event type: regulatory"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-068659","json":"https://secwatch.observer/filing/0001104659-26-068659.json","markdown":"https://secwatch.observer/filing/0001104659-26-068659.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1649989/000110465926068659/0001104659-26-068659-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1649989/000110465926068659/tm2616461d1_8k.htm"},"side_by_side_evidence":null},{"accession":"0001104659-26-068591","ticker":"VYGR","company_name":"Voyager Therapeutics, Inc.","filed_at":"2026-06-01T12:00:26+00:00","headline":"FDA clears IND for VY1706, Voyager's tau-silencing gene therapy for Alzheimer's","event_type":"regulatory","sec_items":["8.01"],"materiality_score":0.65,"calibrated_materiality_score":0.65,"match_reasons":["same SEC item: 8.01","same event type: regulatory"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-068591","json":"https://secwatch.observer/filing/0001104659-26-068591.json","markdown":"https://secwatch.observer/filing/0001104659-26-068591.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1640266/000110465926068591/0001104659-26-068591-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1640266/000110465926068591/tm2616041d1_8k.htm"},"side_by_side_evidence":null}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}